CLINICAL TRIALS PROFILE FOR FLUOROPYRIMIDINE
✉ Email this page to a colleague
Clinical Trials for Fluoropyrimidine
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00002842 ↗ | Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of surgery followed by floxuridine plus systemic fluorouracil and leucovorin in treating patients with liver metastases from colorectal cancer. |
| NCT00002842 ↗ | Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer | Completed | City of Hope Medical Center | Phase 2 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of surgery followed by floxuridine plus systemic fluorouracil and leucovorin in treating patients with liver metastases from colorectal cancer. |
| NCT00010023 ↗ | Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | Completed | National Cancer Institute (NCI) | Phase 1 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of capecitabine combined with cisplatin in treating patients who have locally advanced or metastatic solid tumors . |
| NCT00010023 ↗ | Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | Completed | New York University School of Medicine | Phase 1 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of capecitabine combined with cisplatin in treating patients who have locally advanced or metastatic solid tumors . |
| NCT00010023 ↗ | Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | Completed | NYU Langone Health | Phase 1 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of capecitabine combined with cisplatin in treating patients who have locally advanced or metastatic solid tumors . |
| NCT00016250 ↗ | Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of two different regimens of Ro 31-7453 in treating patients who have recurrent or refractory metastatic colorectal cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Fluoropyrimidine
Condition Name
Clinical Trial Locations for Fluoropyrimidine
Trials by Country
Clinical Trial Progress for Fluoropyrimidine
Clinical Trial Phase
Clinical Trial Sponsors for Fluoropyrimidine
Sponsor Name
